AzTrials
AzTrials

Aneurysmal RuptureNCT05450939

Characteristics of Signal Intensity Gradient in Subarachnoid Hemorrhage After Aneurysmal Rupture

An observational study of Aneurysmal Rupture, run by Chonbuk National University Hospital at 1 site in South Korea.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

10-20% of patients with subarachnoid hemorrhage die before they arrive at the hospital, and about 25% die within 24 hours. About 1% of patients are diagnosed with cerebral aneurysms in imaging tests for health checkups, and many of them experience aneurysmal rupture during their lifetime, so it is not a rare disease. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Aneurysmal Rupture
What is being tested?
Signal intensity gradient
How many people
80 participants
Where
1 siteSouth Korea
Study dates
25 Nov 2021to 31 Dec 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients visited health checkup program or neurology clinic (unruptured group), or emergency department (ruptured group) of a tertiary center

Who may be able to join

  • 1) Patients over 18 years of age who visited our hospital for acute subarachnoid hemorrhage due to rupture of a intracranial aneurysm (2) Among patients satisfying (1), who had intracranial magnetic resonance imaging (time-of-flight (TOF) technique applied; diffusion-weighted imaging, including apparent diffusion coefficient) before subarachnoid hemorrhage occurred.
  • Magnetic resonance imaging performed during the screening period (Time-of-Flight (TOF) technique is applied to intracranial vessel imaging; It also includes diffusion-weighted imaging and apparent diffusion coefficient)
  • Patients diagnosed with unruptured intracranial aneurysm in the final reading of brain MR test
  • Patients who remain without aneurysmal rupture on follow-up intracranial magnetic resonance imaging

Who cannot join

  • Patients under the age of 18
  • Patients with subarachnoid hemorrhage due to causes other than rupture of intracranial aneurysm
  • Patients with poor imaging quality due to artifacts caused by patient movement during brain magnetic resonance imaging examination
  • <Unruptured group>
  • Patients under the age of 18
  • Patients with poor imaging quality due to artifacts caused by patient movement during brain magnetic resonance imaging examination

Trial locations and contacts

1 site in 1 country.

Chan-Hyuk Lee, Dr. contact

+82-10-2822-9803

bluewave0210@gmail.com

South Korea1 site, 1 recruiting
  • Jeonbuk National University Hospital

    Jeonju, Jeollabuk-do, 54907

    Chan-Hyuk Lee, Prof., +82-010-2822-9803, bluewave0210@gmail.com

    Recruiting

Other trials in South Korea

About this study

Official title: Analysis of Hemodynamic Characteristics Using Signal Intensity Gradient of Brain Magnetic Resonance Imaging in Patients With Subarachnoid Hemorrhage After Rupture of Intracranial Aneurysm

10-20% of patients with subarachnoid hemorrhage die before they arrive at the hospital, and about 25% die within 24 hours. About 1% of patients are diagnosed with cerebral aneurysms in imaging tests for health checkups, and many of them experience aneurysmal rupture during their lifetime, so it is not a rare disease. Wall shear stress is known to be a factor that reflects the state of blood vessels, and particularly plays an important role in the patency of the intima of blood vessels. In the meantime, computed fluid dynamics (CFD), a representative method for calculating wall shear stress, assumes a virtual rigid pipe and applies a preset value. This does not accurately reflect the physiological and dynamic state of the actual blood vessel. The investigators intend to measure the patient's wall shear stress using the SIG of the MRA-TOF technique, which reflects the physiological characteristics of individual patients, and to analyze the association with rupture of the intracranial aneurysm.

Being tested
Signal intensity gradient
Keywords
Signal intensity gradient, Wall shear stress, Aneurysmal rupture, Time-of-Flight MRI

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Signal intensity gradientDiagnostic test

    In time-of-flight (TOF) MRA, The signal intensities at the iso-point (Φa; signal intensity at position A [Xa] along the arterial contour line) and at the inner point (Φb; signal intensity at position B [Xb]) were calculated by using a trilinear interpolation algorithm based on the positions and signal intensities in the eight neighboring voxels. The signal intensities of TOF-MRA were normalized to eliminate the offset and scale effects across the MRA datasets of participants. For each iso-point (position A), the SIG was calculated from the difference in signal intensities between points A and B as follows:

    Scalar SIG, SI/mm = (Φb - Φa) / │Xb - Xa│ (1)

    Vector SIG, SI/mm = (Φb - Φa) n / │Xb - Xa│ (2)

Study groups in NCT05450939
Study groupRoleWhat they receive
Ruptured groupGroup of subarachnoid hemorrhage after rupture of intracranial aneurysm
Receives: Diagnostic Test: Signal intensity gradient
Unruptured groupGroup of inexperience of aneurysmal rupture during specific period
Receives: Diagnostic Test: Signal intensity gradient

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Degree of signal intensity gradient in aneurysmal sac

    The investigators will measure the degree of signal intensity gradient (SIG) from brain TOF-MRA in aneurysmal sac.

    The measured SIG in ruptured group would be lower than that in unruptured group.

    Measured: Average 4-6 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Jul 2022
  2. Study start25 Nov 2021
  3. Primary completion31 Jul 2023 (estimated)
  4. Study completion31 Dec 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Retrospective
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05450939
Sponsor's protocol ID
SIGSAH
Status last verified
Jul 2022
First submitted
29 Jun 2022
Last updated
11 Jul 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Han KS, Lee SH, Ryu HU, Park SH, Chung GH, Cho YI, Jeong SK. Direct Assessment of Wall Shear Stress by Signal Intensity Gradient from Time-of-Flight Magnetic Resonance Angiography. Biomed Res Int. 2017;2017:7087086. doi: 10.1155/2017/7087086. Epub 2017 Aug 16.

    PubMed 28900625
  • Suzuki T, Stapleton CJ, Koch MJ, Tanaka K, Fujimura S, Suzuki T, Yanagisawa T, Yamamoto M, Fujii Y, Murayama Y, Patel AB. Decreased wall shear stress at high-pressure areas predicts the rupture point in ruptured intracranial aneurysms. J Neurosurg. 2019 Mar 15;132(4):1116-1122. doi: 10.3171/2018.12.JNS182897. Print 2020 Apr 1.

    PubMed 30875692
  • Lee WJ, Jeong SK, Han KS, Lee SH, Ryu YJ, Sohn CH, Jung KH. Impact of Endothelial Shear Stress on the Bilateral Progression of Unilateral Moyamoya Disease. Stroke. 2020 Mar;51(3):775-783. doi: 10.1161/STROKEAHA.119.028117. Epub 2019 Dec 20.

    PubMed 31856692
  • Lee CH, Kwak HS, Kang HS, Jung KH, Jeong SK. Geometric versus Hemodynamic Indexes for Rupture-Destined Aneurysms: A Retrospective Cohort and a Repeated-Measures Study. Cerebrovasc Dis. 2024;53(3):327-334. doi: 10.1159/000533167. Epub 2023 Sep 11.

    PubMed 37696264

Questions about this trial

What is this clinical trial studying?

An observational study of Aneurysmal Rupture, run by Chonbuk National University Hospital at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 11 Jul 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Chan-Hyuk Lee, Dr. (+82-10-2822-9803, bluewave0210@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Degree of signal intensity gradient in aneurysmal sac (time frame: Average 4-6 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05450939, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Jul 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in